vs
Lakeside Holding Ltd（LSH）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
SWK Holdings Corp的季度营收约是Lakeside Holding Ltd的1.2倍（$8.7M vs $7.0M），Lakeside Holding Ltd同比增速更快（95.0% vs -29.7%）
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
LSH vs SWKH — 直观对比
营收规模更大
SWKH
是对方的1.2倍
$7.0M
营收增速更快
LSH
高出124.7%
-29.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $8.7M |
| 净利润 | $-1.6M | $-19.4M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -21.3% | 9.9% |
| 净利率 | -22.6% | — |
| 营收同比 | 95.0% | -29.7% |
| 净利润同比 | 18.7% | -430.2% |
| 每股收益（稀释后） | $-0.08 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSHSWKH
| Q4 25 | $7.0M | $8.7M | ||
| Q3 25 | $6.1M | $10.9M | ||
| Q2 25 | $6.3M | $10.1M | ||
| Q1 25 | $3.8M | $11.8M | ||
| Q4 24 | $3.6M | $12.4M | ||
| Q3 24 | $4.1M | $10.4M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | — | $11.4M |
净利润LSHSWKH
| Q4 25 | $-1.6M | $-19.4M | ||
| Q3 25 | $-1.4M | $8.8M | ||
| Q2 25 | $-893.1K | $3.5M | ||
| Q1 25 | $-1.1M | $4.5M | ||
| Q4 24 | $-1.9M | $5.9M | ||
| Q3 24 | $-1.3M | $3.5M | ||
| Q2 24 | — | $3.7M | ||
| Q1 24 | — | $468.0K |
毛利率LSHSWKH
| Q4 25 | 27.2% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率LSHSWKH
| Q4 25 | -21.3% | 9.9% | ||
| Q3 25 | -20.8% | 61.3% | ||
| Q2 25 | -8.9% | 46.1% | ||
| Q1 25 | -28.2% | 68.6% | ||
| Q4 24 | -55.6% | 44.7% | ||
| Q3 24 | -32.5% | 39.2% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 9.5% |
净利率LSHSWKH
| Q4 25 | -22.6% | — | ||
| Q3 25 | -22.2% | 80.7% | ||
| Q2 25 | -14.2% | 35.2% | ||
| Q1 25 | -28.2% | 38.4% | ||
| Q4 24 | -54.1% | 47.5% | ||
| Q3 24 | -32.7% | 33.3% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 4.1% |
每股收益（稀释后）LSHSWKH
| Q4 25 | $-0.08 | $-1.59 | ||
| Q3 25 | $-0.09 | $0.72 | ||
| Q2 25 | $-0.11 | $0.29 | ||
| Q1 25 | $-0.14 | $0.37 | ||
| Q4 24 | $-0.26 | $0.47 | ||
| Q3 24 | $-0.18 | $0.28 | ||
| Q2 24 | — | $0.30 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | $42.8M |
| 总债务越低越好 | $2.4M | $33.0M |
| 股东权益账面价值 | $12.2M | $235.1M |
| 总资产 | $24.3M | $272.4M |
| 负债/权益比越低杠杆越低 | 0.20× | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资LSHSWKH
| Q4 25 | $1.6M | $42.8M | ||
| Q3 25 | $4.5M | $10.2M | ||
| Q2 25 | $5.0M | $8.0M | ||
| Q1 25 | $1.5M | $29.8M | ||
| Q4 24 | $1.1M | $5.9M | ||
| Q3 24 | $2.7M | $17.2M | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | — | $5.5M |
总债务LSHSWKH
| Q4 25 | $2.4M | $33.0M | ||
| Q3 25 | $2.4M | $33.0M | ||
| Q2 25 | $1.4M | $33.0M | ||
| Q1 25 | $774.2K | $33.0M | ||
| Q4 24 | $784.8K | $33.0M | ||
| Q3 24 | $589.9K | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益LSHSWKH
| Q4 25 | $12.2M | $235.1M | ||
| Q3 25 | $7.0M | $254.2M | ||
| Q2 25 | $2.8M | $246.5M | ||
| Q1 25 | $749.8K | $292.7M | ||
| Q4 24 | $1.6M | $288.7M | ||
| Q3 24 | $3.6M | $283.4M | ||
| Q2 24 | — | $282.8M | ||
| Q1 24 | — | $279.9M |
总资产LSHSWKH
| Q4 25 | $24.3M | $272.4M | ||
| Q3 25 | $18.6M | $289.4M | ||
| Q2 25 | $14.4M | $285.7M | ||
| Q1 25 | $9.9M | $331.3M | ||
| Q4 24 | $9.8M | $332.2M | ||
| Q3 24 | $10.8M | $321.3M | ||
| Q2 24 | — | $321.0M | ||
| Q1 24 | — | $322.0M |
负债/权益比LSHSWKH
| Q4 25 | 0.20× | 0.14× | ||
| Q3 25 | 0.35× | 0.13× | ||
| Q2 25 | 0.48× | 0.13× | ||
| Q1 25 | 1.03× | 0.11× | ||
| Q4 24 | 0.48× | 0.11× | ||
| Q3 24 | 0.16× | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-453.5K | $27.3M |
| 自由现金流经营现金流 - 资本支出 | — | $26.8M |
| 自由现金流率自由现金流/营收 | — | 308.1% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $43.2M |
8季度趋势，按日历期对齐
经营现金流LSHSWKH
| Q4 25 | $-453.5K | $27.3M | ||
| Q3 25 | $-4.0M | $906.0K | ||
| Q2 25 | $-483.7K | $7.8M | ||
| Q1 25 | $-238.3K | $8.3M | ||
| Q4 24 | $-530.2K | $23.0M | ||
| Q3 24 | $-1.4M | $6.3M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | $4.4M |
自由现金流LSHSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | $-497.4K | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | $-560.5K | $22.9M | ||
| Q3 24 | $-1.4M | $6.3M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | — |
自由现金流率LSHSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | -7.9% | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | -15.6% | 185.3% | ||
| Q3 24 | -34.5% | 60.4% | ||
| Q2 24 | — | 49.7% | ||
| Q1 24 | — | — |
资本支出强度LSHSWKH
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 0.0% | 0.8% | ||
| Q4 24 | 0.8% | 1.1% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
现金转化率LSHSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
